Evidence map›Paper›PMID 37656705›Full record

ArticlePloS one2023

Machine learning to predict risk for community-onset Staphylococcus aureus infections in children living in southeastern United States.

Xiting Lin, Ruijin Geng, Kurt Menke, Mike Edelson, Fengxia Yan, Traci Leong, George S Rust, Lance A Waller, Erica L Johnson, Lilly Cheng Immergluck

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Veterinary sciences · 2025
    Review
  4. Article
  5. Risk Factors for Methicillin-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiting LinMorehouse School of Medicine, Department of Microbiology/Biochemistry/Immunology and Clinical Research Center, Atlanta, Georgia, United States of America.ORCID 0000-0003-3836-4515
Ruijin GengMorehouse School of Medicine, Department of Microbiology/Biochemistry/Immunology and Clinical Research Center, Atlanta, Georgia, United States of America.
Kurt MenkeSeptima, Copenhagen, Denmark.
Mike EdelsonInterDev, Roswell, Georgia, United States of America.
Fengxia YanMorehouse School of Medicine, Department of Community Health and Preventive Medicine, Atlanta, Georgia, United States of America.
Traci LeongEmory University, Rollins School of Public Health, Department of Biostatistics & Bioinformatics, Atlanta, Georgia, United States of America.
George S RustCollege of Medicine, and Center for Medicine and Public Health, Florida State University, Tallahassee, Florida, United States of America.
Lance A WallerEmory University, Rollins School of Public Health, Department of Biostatistics & Bioinformatics, Atlanta, Georgia, United States of America.
Erica L JohnsonMorehouse School of Medicine, Department of Microbiology/Biochemistry/Immunology and Clinical Research Center, Atlanta, Georgia, United States of America.
Lilly Cheng ImmergluckMorehouse School of Medicine, Department of Microbiology/Biochemistry/Immunology and Clinical Research Center, Atlanta, Georgia, United States of America.ORCID 0000-0001-8542-896X
Morehouse School of Medicine · USEmory University · USFlorida State University · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI Dana Boyd Barr · 2013 to 2026
$22.6M
Quanitifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesU01AI148069 · NIAID · EMORY UNIVERSITY · PI VAZQUEZ PROKOPEC, GONZALO MARTIN · 2020 to 2024
$6.4M
Assessing the 5-Year Effects of a 500-day Liquefied Petroleum Gas Cooking Intervention: Continued Follow up of Participants from the Household Air Pollution Intervention Network (HAPIN) trialR01ES033530 · NIEHS · EMORY UNIVERSITY · PI CLASEN, THOMAS F, PEEL, JENNIFER L · 2022 to 2025
$5.5M
Limited interaction cohort to identify determinants of viral suppression in MSM and transfeminine individuals living with HIV: A multilevel approachUG3AI176853 · NIAID · EMORY UNIVERSITY · PI SIEGLER, AARON JULIUS, SULLIVAN, PATRICK SEAN · 2023 to 2024
$5.0M
CE19-001, Injury Prevention Research Center at EmoryR49CE003072 · CE · EMORY UNIVERSITY · PI RUPP, JONATHAN D. · 2018 to 2023
$4.4M
Improving statistical methods for small area estimates of public health indicators and demographic characteristicsR01HD092580 · NICHD · EMORY UNIVERSITY · PI Lance A Waller · 2018 to 2026
$2.3M
Training in Advanced Data Analytics to End Drug-Related Harms (TADA)T32DA050552 · NIDA · EMORY UNIVERSITY · PI Howard H Chang, Hannah LF Cooper · 2020 to 2026
$1.6M
Identifying Risk Factors for Leprosy Transmission Related to Co-infections, Unsafe WASH and Undernutrition Using Novel Serologic Multiplex and High Resolution Metabolomic AssaysR01AI149527 · NIAID · EMORY UNIVERSITY · PI FAIRLEY, JESSICA K. · 2020 to 2023
$624k
Project HIRaCAARI: Empowering Communities to Stop the Spread of Antibiotic Resistant Infections through Accessible Health InformationG08LM013190 · NLM · MOREHOUSE SCHOOL OF MEDICINE · PI IMMERGLUCK, LILLY HSI-CHIH, WELMAKER, ROLAND B · 2019 to 2021
$434k
Neighborhood transportation vulnerability and geographic patterns of diabetes-related limb lossR21MD017943 · NIMHD · EMORY UNIVERSITY · PI CHANG, HOWARD H, SCHECHTER, MARCOS C. · 2022 to 2023
$430k
ACL HHS R49CE003072AHRQ HHS K08 HS024338NCATS NIH HHS UL1 TR002378NCIPC CDC HHS R49 CE003072NIAID NIH HHS R01 AI149527NIAID NIH HHS U01 AI148069NIAID NIH HHS UG3 AI176853NICHD NIH HHS R01 HD092580NIDA NIH HHS T32 DA050552NIEHS NIH HHS P30 ES019776NIEHS NIH HHS R01 ES033530NIMHD NIH HHS R21 MD017943NLM NIH HHS G08 LM013190
6 · The paper itself

Abstract

Staphylococcus aureus (S. aureus) is known to cause human infections and since the late 1990s, community-onset antibiotic resistant infections (methicillin resistant S. aureus (MRSA)) continue to cause significant infections in the United States. Skin and soft tissue infections (SSTIs) still account for the majority of these in the outpatient setting. Machine learning can predict the location-based risks for community-level S. aureus infections. Multi-year (2002-2016) electronic health records of children <19 years old with S. aureus infections were queried for patient level data for demographic, clinical, and laboratory information. Area level data (Block group) was abstracted from U.S. Census data. A machine learning ecological niche model, maximum entropy (MaxEnt), was applied to assess model performance of specific place-based factors (determined a priori) associated with S. aureus infections; analyses were structured to compare methicillin resistant (MRSA) against methicillin sensitive S. aureus (MSSA) infections. Differences in rates of MRSA and MSSA infections were determined by comparing those which occurred in the early phase (2002-2005) and those in the later phase (2006-2016). Multi-level modeling was applied to identify risks factors for S. aureus infections. Among 16,124 unique patients with community-onset MRSA and MSSA, majority occurred in the most densely populated neighborhoods of Atlanta's metropolitan area. MaxEnt model performance showed the training AUC ranged from 0.771 to 0.824, while the testing AUC ranged from 0.769 to 0.839. Population density was the area variable which contributed the most in predicting S. aureus disease (stratified by CO-MRSA and CO-MSSA) across early and late periods. Race contributed more to CO-MRSA prediction models during the early and late periods than for CO-MSSA. Machine learning accurately predicts which densely populated areas are at highest and lowest risk for community-onset S. aureus infections over a 14-year time span.

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAdultChildHumansMachine LearningSoutheastern United StatesStaphylococcus aureusYoung Adult

Identifiers

PMID37656705
PMCPMC10473480
OpenAlexW4386365300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.